Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariola Peczkowska

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Endocrine-Related Cancer|January 18, 2015
A registry-based study of thyroid paraganglioma: histological and genetic characteristicsErnst von Dobschuetz, Helena Leijon, Camilla Schalin-Jäntti, et al.
Endocrine-Related Cancer|May 26, 2018
65 YEARS OF THE DOUBLE HELIX: Genetics informs precision practice in the diagnosis and management of pheochromocytomaHartmut P Neumann, William F Young, Tobias Krauss, et al.
Endocrine-Related Cancer|July 28, 2010
Systematic comparison of sporadic and syndromic pancreatic islet cell tumorsZoran Erlic, Ursula Ploeckinger, Alberto Cascon, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2007
Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1Birke Bausch, Wiktor Borozdin, Victor F Mautner, et al.
Endocrine-Related Cancer|June 27, 2017
The penetrance of MEN2 pheochromocytoma is not only determined by <i>RET</i> mutationsFrederic Castinetti, Ana Luiza Maia, Mariola Peczkowska, et al.
Endocrine Connections|May 7, 2020
Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter studyLouise Vølund Larsen, Delphine Mirebeau-Prunier, Tsuneo Imai, et al.
Human Mutation|October 28, 2010
Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10Karin Frank-Raue, Lisa A Rybicki, Zoran Erlic, et al.
JAMA Oncology|April 7, 2017
Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed PreventionBirke Bausch, Francesca Schiavi, Ying Ni, et al.
JAMA Network Open|August 10, 2019
Comparison of Pheochromocytoma-Specific Morbidity and Mortality Among Adults With Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing AdrenalectomyHartmut P H Neumann, Uliana Tsoy, Irina Bancos, et al.
The Lancet. Oncology|April 22, 2014
Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based studyFrederic Castinetti, Xiao-Ping Qi, Martin K Walz, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Endocrine-Related Cancer|January 18, 2015
A registry-based study of thyroid paraganglioma: histological and genetic characteristicsErnst von Dobschuetz, Helena Leijon, Camilla Schalin-Jäntti, et al.
Endocrine-Related Cancer|May 26, 2018
65 YEARS OF THE DOUBLE HELIX: Genetics informs precision practice in the diagnosis and management of pheochromocytomaHartmut P Neumann, William F Young, Tobias Krauss, et al.
Endocrine-Related Cancer|July 28, 2010
Systematic comparison of sporadic and syndromic pancreatic islet cell tumorsZoran Erlic, Ursula Ploeckinger, Alberto Cascon, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2007
Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1Birke Bausch, Wiktor Borozdin, Victor F Mautner, et al.
Endocrine-Related Cancer|June 27, 2017
The penetrance of MEN2 pheochromocytoma is not only determined by <i>RET</i> mutationsFrederic Castinetti, Ana Luiza Maia, Mariola Peczkowska, et al.
Endocrine Connections|May 7, 2020
Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter studyLouise Vølund Larsen, Delphine Mirebeau-Prunier, Tsuneo Imai, et al.
Human Mutation|October 28, 2010
Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10Karin Frank-Raue, Lisa A Rybicki, Zoran Erlic, et al.
JAMA Oncology|April 7, 2017
Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed PreventionBirke Bausch, Francesca Schiavi, Ying Ni, et al.
JAMA Network Open|August 10, 2019
Comparison of Pheochromocytoma-Specific Morbidity and Mortality Among Adults With Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing AdrenalectomyHartmut P H Neumann, Uliana Tsoy, Irina Bancos, et al.
The Lancet. Oncology|April 22, 2014
Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based studyFrederic Castinetti, Xiao-Ping Qi, Martin K Walz, et al.
Pageof 4